Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
2,657 INR | -2.80% | +1.95% | +4.95% |
Mar. 04 | Colgate-Palmolive Limited Appoints Sanjay Gupta as an Independent Director | CI |
Jan. 30 | Gillette India's Q2 profit rises on better demand | RE |
Summary
- The company has strong fundamentals. More than 70% of companies have a lower mix of growth, profitability, debt and visibility.
- Overall, and from a short-term perspective, the company presents an interesting fundamental situation.
Strengths
- The company's EBITDA/Sales ratio is relatively high and results in high margins before depreciation, amortization and taxes.
- Margins returned by the company are among the highest on the stock exchange list. Its core activity clears big profits.
- Thanks to a sound financial situation, the firm has significant leeway for investment.
- For the past year, analysts covering the stock have been revising their EPS expectations upwards in a significant manner.
- For the last few months, EPS revisions have remained quite promising. Analysts now anticipate higher profitability levels than before.
- Considering the small differences between the analysts' various estimates, the group's business visibility is good.
- Historically, the company has been releasing figures that are above expectations.
Weaknesses
- The company's valuation in terms of earnings multiples is rather high. Indeed, the firm is getting paid 57.26 times its estimated earnings per share for the ongoing year.
- The company's "enterprise value to sales" ratio is among the highest in the world.
- In relation to the value of its tangible assets, the company's valuation appears relatively high.
- The valuation of the company is particularly high given the cash flows generated by its activity.
- The company is not the most generous with respect to shareholders' compensation.
Ratings chart - Surperformance
Chart ESG Refinitiv
Sector: Personal Products
1st Jan change | Capi. | Investor Rating | ESG Refinitiv | |
---|---|---|---|---|
+4.95% | 8.95B | B | ||
+10.01% | 380B | C- | ||
+0.30% | 123B | B- | ||
+10.74% | 72.81B | A+ | ||
-15.00% | 65.98B | A- | ||
-6.18% | 38.94B | - | ||
-1.62% | 33.11B | B- | ||
-0.88% | 16.95B | A- | ||
+7.32% | 14.96B | B | ||
-6.92% | 11.26B | C+ |
Financials
Valuation
Momentum
Consensus
Business Predictability
Environment
Governance
Controversy
Technical analysis
- Stock
- Equities
- Stock Colgate-Palmolive (India) Limited - Bombay S.E.
- Ratings Colgate-Palmolive (India) Limited